ABC transporters and drug resistance in parasitic protozoa

International Journal of Antimicrobial Agents

Volumn 22, Issue 3, 2003, Pages 301-317

  Klokouzas, Antonios ^a   Shahi, Sanjay ^a   Hladky, Stephen B ^a   Barrand, Margery A ^a   Van Veen, Hendrik W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

ABC transporters; Drug resistance; Protozoa

Indexed keywords

4 AMINOQUINOLINE DERIVATIVE; ABC TRANSPORTER; AMODIAQUINE; ANTIMONY DERIVATIVE; ARSENIC TRIOXIDE; ARTEMISININ DERIVATIVE; CADMIUM; CHLOROQUINE; CINCHONA ALKALOID; DAPSONE; DAUNORUBICIN; FOLIC ACID ANTAGONIST; HALOFANTRINE; MEFLOQUINE; MELARSOPROL; MULTIDRUG RESISTANCE PROTEIN 1; PROGUANIL; PUROMYCIN; PYRIMETHAMINE; QUININE; QUINOLINE DERIVATIVE; SPERMIDINE; SULFADOXINE; SULFONAMIDE; SULFONE DERIVATIVE; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG; VINBLASTINE; XENOBIOTIC AGENT; ZINC;

AFRICAN TRYPANOSOMIASIS; AMINO ACID SEQUENCE; CARDIOTOXICITY; ENTAMOEBA; GENE AMPLIFICATION; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENOME; HUMAN; LEISHMANIA; LEISHMANIASIS; MULTIDRUG RESISTANCE; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITOSIS; PHYLOGENY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SEQUENCE HOMOLOGY; TRYPANOSOMA;

EID: 0042764352     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00210-3     Document Type: Article

References (142)

1. Olliaro P., Cattani J., Wirth D. Malaria, the submerged disease. J. Am. Med. Assoc. 275:1996;230-233.
2. Marsh K. Malaria disaster in Africa. Lancet. 352:(9132):1998;924.
3. Guerrant R. Cryptosporidiosis: an emerging, highly infectious threat. Emerg. Infect. Dis. 3:(1):1997;51-57.
4. Ashford R.W., Desjeux P., deRaadt P. Estimation of populations at risk of infection with leishmaniasis. Parasitol. Today. 8:1992;104-105.
5. Colford J.M. Jr, Tager I.B., Hirozawa A.M., Lemp G.F., Aragon T., Petersen C. Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival. Am. J. Epidemiol. 144:(9):1996;807-816.
6. Johnston D.A., Blaxter M.L., Degrave W.M., Foster J., Ivens A.C., Melville S.E. Genomics and the biology of parasites. Bioessays. 21:1999;131-147.
7. Ochoa C., Martinez A.R. Antiparasitic protozoan vaccines. Expert Opin. Ther. 11:2001;211-219.
8. Borst P., Ouellette M. New mechanisms of drug resistance in parasitic protozoa. Annu. Rev. Microbiol. 49:1995;427-460.
9. Papadopoulou B., Kundig C., Singh A., Ouellette M. Drug resistance in Leishmania: similarities and differences to other organisms. Drug Resist. Updates. 1:(4):1998;266-278.
10. Peel S.A. The ABC transporter genes of Plasmodium falciparum and drug resistance. Drug Resist. Updates. 4:(1):2001;66-74.
11. Ouellette M., Legare D., Papadopoulou B. Multidrug resistance and ABC transporters in parasitic protozoa. J. Mol. Microbiol. Biotechnol. 3:(2):2001;201-206.
12. Ullman B. Multidrug resistance and P-glycoproteins in parasitic protozoa. J. Bioenerg. Biomembr. 27:(1):1995;77-84.
13. Burri C., Keiser J. Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment. Trop. Med. Int. Health. 6:(5):2001;412-420.
14. Orozco E., Perez D.G., Gomez M.Z., Ayala P. Multidrug resistance in Entamoeba histolytica. Parasitol. Today. 11:1995;473-475.
15. Filardi L.S., Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans. R. Soc. Trop. Med. Hyg. 81:1987;755-759.
16. Buckner F.S., Wilson A.J., White T.C., Van Voorhis W.C. Induction of resistance to azole drugs in Trypanosoma cruzi. Antimicrob. Agents Chemother. 42:(12):1998;3245-3250.
17. Higgins C.F. The ABC transporter channel superfamily - an overview. Semin. Cell Biol. 4:1993;1-5.
18. Deeley R.G., Cole S.P.C. Function, evolution and structure of multidrug resistance protein (MRP). Semin. Cancer Biol. 8:(3):1997;193-204.
19. van Veen H.W., Konings W.N. Multidrug transporters from bacteria to man: similarities in structure and function. Semin. Cancer Biol. 8:(3):1997;183-191.
20. Borst P., Evers R., Kool M., Wijnholds J. The multidrug resistance protein family. Biochim. Biophys. Acta-Biomembr. 1461:(2):1999;347-357.
21. Blackmore C.G., McNaughton P.A., van Veen H.W. Multidrug transporters in prokaryotic and eukaryotic cells: physiological functions and transport mechanisms. Mol. Membr. Biol. 18:(1):2001;97-103.
22. Borst P., Elferink R.O. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71:2002;537-592.
23. Walker J.E., Saraste M., Runswick M.J., Gay N.J. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1:(8):1982;945-951.
24. Higgins C.F., Gallagher M.P., Mimmack M.L., Pearce S.R. A family of closely related ATP-binding subunits from prokaryotic and eukaryotic cells. BioEssays. 8:1988;111-116.
25. Krogstad D.J., Gluzman I.Y., Kyle D.E., et al. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science. 238:(4831):1987;1283-1285.
26. Foote S.J., Thompson J.K., Cowman A.F., Kemp D.J. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell. 57:(6):1989;921-930.
27. Wilson C.M., Serrano A.E., Wasley A., Bogenschutz M.P., Shankar A.H., Wirth D.F. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science. 244:(4909):1989;1184-1186.
28. Ouellette M., Fase-Fowler F., Borst P. The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel P-glycoprotein gene. EMBO J. 9:(4):1990;1027-1033.
29. Callahan H.L., Beverley S.M. Heavy metal resistance: a new role for P-glycoproteins in Leishmania. J. Biol. Chem. 266:(28):1991;18427-18430.
30. Henderson D.M., Sifri C.D., Rodgers M., Wirth D.F., Hendrickson N., Ullman B. Multidrug resistance in Leishmania-donovani is conferred by amplification of a gene homologous to the mammalian mdr-1 gene. Mol. Cell. Biol. 12:(6):1992;2855-2865.
31. Hendrickson N., Sifri C.D., Henderson D.M., Allen T., Wirth D.F., Ullman B. Molecular characterization of the ldmdr1 multidrug-resistance gene from Leishmania-donovani. Mol. Biochem. Parasitol. 60:(1):1993;53-64.
32. Chow L.M., Wong A.K., Ullman B., Wirth D.F. Cloning and functional analysis of an extrachromosomally amplified multidrug resistance-like gene in Leishmania enriettii. Mol. Biochem. Parasitol. 60:(2):1993;195-208.
33. Gueiros F.J., Viola J.P.B., Gomes F.C.A., et al. Leishmania amazonensis: multidrug resistance in vinblastine- resistant promastigotes is associated with rhodamine 123 efflux, DNA amplification, and RNA overexpression of a Leishmania mdr1 gene. Exp. Parasitol. 81:(4):1995;480-490.
34. Chiquero M.J., Perez-Victoria J.M., O'Valle F., et al. Altered drug membrane permeability in a multidrug-resistant Leishmania tropica line. Biochem. Pharmacol. 55:(2):1998;131-139.
35. Katakura K., Iwanami M., Ohtomo H., Fujise H., Hashiguchi Y. Structural and functional analysis of the LaMDR1 multidrug resistance gene in Leishmania amazonensis. Biochem. Biophys. Res. Commun. 255:(2):1999;289-294.
36. Samuelson J., Ayala P., Orozco E., Wirth D. Emetine-resistant mutants of Entamoeba histolytica overexpress mRNAs for multidrug resistance. Mol. Biochem. Parasitol. 38:(2):1990;281-290.
37. Descoteaux S., Ayala P., Samuelson J., Orozco E. Increase in mRNA of multiple Eh pgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites. Gene. 164:(1):1995;179-184.
38. Descoteaux S., Ayala P., Orozco E., Samuelson J. Primary sequences of two P-glycoprotein genes of Entamoeba histolytica. Mol. Biochem. Parasitol. 54:(2):1992;201-211.
39. Descoteaux S., Shen P.S., Ayala P., Orozco E., Samuelson J. P-glycoprotein genes of Entamoeba histolytica. Arch. Med. Res. 23:(2):1992;23-25.
40. Ghosh S.K., Lohia A., Kumar A., Samuelson J. Overexpression of P-glycoprotein gene 1 by transfected Entamoeba histolytica confers emetine-resistance. Mol. Biochem. Parasitol. 82:(2):1996;257-260.
41. Johnson P.J., Schuck B.L., Delgadillo M.G. Analysis of a single-domain P-glycoprotein-like gene in the early- diverging protist Trichomonas vaginalis. Mol. Biochem. Parasitol. 66:(1):1994;127-137.
42. Maser P., Kaminsky R. Identification of three ABC transporter genes in Trypanosoma brucei spp. Parasitol. Res. 84:(2):1998;106-111.
43. Shahi S.K., Krauth-Siegel R.L., Clayton C.E. Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance in Trypanosoma brucei. Mol. Microbiol. 43:(5):2002;1129-1138.
44. Volkman S.K., Wilson C.M., Wirth D.F. Stage-specific transcripts of the Plasmodium falciparum pfmdr 1 gene. Mol. Biochem. Parasitol. 57:1993;203-211.
45. Zalis M.G., Wilson C.M., Zhang Y., Wirth D.F. Characterization of the pfmdr2 gene for Plasmodium falciparum. Mol. Biochem. Parasitol. 62:(1):1993;83-92.
46. Zalis M.G., Wilson C.M., Zhang Y., Wirth D.F. Characterization of the pfmdr2 gene for Plasmodium-falciparum. Mol. Biochem. Parasitol. 63:(2):1994;311-311.
47. Rubio J.P., Cowman A.F. Plasmodium falciparum: the pfmdr2 protein is not overexpressed in chloroquine-resistant isolates of the malaria parasite. Exp. Parasitol. 79:(2):1994;137-147.
48. Kajiji S., Talbot F., Grizzuti K., et al. Functional-analysis of p-glycoprotein mutants identifies predicted transmembrane domain-11 as a putative drug-binding site. Biochemistry. 32:(16):1993;4185-4194.
49. Ortiz D.F., Kreppel L., Speiser D.M., Scheel G., McDonald G., Ow D.W. Heavy metal tolerance in the fission yeast requires an ATP-binding cassette-type vacuolar membrane transporter. EMBO J. 11:(10):1992;3491-3499.
50. Legare D., Hettema E., Ouellette M. The P-glycoprotein-related gene family in Leishmania. Mol. Biochem. Parasitol. 68:(1):1994;81-91.
51. Ellenberger T.E., Beverley S.M. Multiple drug resistance and conservative amplification of the H region in Leishmania major. J. Biol. Chem. 264:(25):1989;15094-150103.
52. Ouellette M., Hettema E., Wust D., Fase-Fowler F., Borst P. Direct and inverted DNA repeats associated with P-glycoprotein gene amplification in drug resistant Leishmania. EMBO J. 10:(4):1991;1009-1016.
53. Grondin K., Papadopoulou B., Ouellette M. Homologous recombination between direct repeat sequences yields P- glycoprotein containing amplicons in arsenite resistant Leishmania. Nucleic Acids Res. 21:(8):1993;1895-1901.
54. Gamarro F., Chiquero M.J., Amador M.V., Legare D., Ouellette M., Castanys S. P-glycoprotein overexpression in methotrexate-resistant Leishmania tropica. Biochem. Pharmacol. 47:(11):1994;1939-1947.
55. Perkins M.E., Volkman S., Wirth D.F., Le Blancq S.M. Characterization of an ATP-binding cassette transporter in Cryptosporidium parvum. Mol. Biochem. Parasitol. 87:(1):1997;117-122.
56. Perkins M.E., Riojas Y.A., Wu T.W., Le Blancq S.M. CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages. Proc. Natl. Acad. Sci. USA. 96:1999;5734-5739.
57. Zapata F., Perkins M.E., Riojas Y.A., Wu T.W., Le Blancq S.M. The Cryptosporidium parvum ABC protein family. Mol. Biochem. Parasitol. 120:2002;157-161.
58. Devidas S., Guggino W.B. CFTR: domains, structure, and function. J. Bioenerg. Biomembr. 29:(5):1997;443-451.
59. Dallagiovanna B., Gamarro F., Castanys S. Molecular characterization of a P-glycoprotein-related tcpgp2 gene in Trypanosoma cruzi. Mol. Biochem. Parasitol. 75:(2):1996;145-157.
60. Torres C., Barreiro L., Dallagiovanna B., Gamarro F., Castanys S. Characterization of a new ATP-binding cassette transporter in Trypanosoma cruzi associated to a L1Tc retrotransposon. Biochim. Biophys. Acta. 1489:(2-3):1999;428-432.
61. Bozdech Z., Delling U., Volkman S.K., Cowman A.F., Schurr E. Cloning and sequence analysis of a novel member of the ATP-binding cassette (ABC) protein gene family from Plasmodium falciparum. Mol. Biochem. Parasitol. 81:(1):1996;41-51.
62. Olliaro P.L., Bryceson A.D.M. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol. Today. 9:1993;323-328.
63. Berman J.D. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24:(4):1997;684-703.
64. Faraut-Gambarelli F., Piarroux R., Deniau M., et al. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob. Agents Chemother. 41:(4):1997;827-830.
65. Sundar S., Agrawal N.K., Sinha P.R., Horwith G.S., Murray H.W. Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Ann. Intern. Med. 127:(2):1997;133-137.
66. Papadopoulou B., Roy G., Dey S., Rosen B.P., Ouellette M. Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance. J. Biol. Chem. 269:(16):1994;11980-11986.
67. Grondin K., Roy G., Ouellette M. Formation of extrachromosomal circular amplicons with direct or inverted duplications in drug-resistant Leishmania tarentolae. Mol. Cell. Biol. 16:(7):1996;3587-3595.
68. Ouellette M., Haimeur A., Grondin K., Legare D., Papadopoulou B. ABC transporters: biochemical, cellular, and molecular aspects. Ambudkar S.V., Gottesman M.M. Methods enzymology. 1998;Academic Press, San Diego.
69. Cowman A.F., Lew A.M. Antifolate drug selection results in duplication and rearrangement of chromosome 7 in Plasmodium chabaudi. Mol. Cell Biol. 9:(11):1989;5182-5188.
70. Grondin K., Haimeur A., Mukhopadhyay R., Rosen B.P., Ouellette M. Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. EMBO J. 16:(11):1997;3057-3065.
71. Mukhopadhyay R., Dey S., Xu N., et al. Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania. Proc. Natl. Acad. Sci. USA. 93:(19):1996;10383-10387.
72. Haimeur A., Guimond C., Pilote S., et al. Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania. Mol. Microbiol. 34:(4):1999;726-735.
73. Haimeur A., Brochu C., Genest P.A., Papadopoulou B., Ouellette M. Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae. Mol. Biochem. Parasitol. 108:(1):2000;131-135.
74. Borst P., Evers R., Kool M., Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92:(16):2000;1295-1302.
75. Dey S., Ouellette M., Lightbody J., Papadopoulou B., Rosen B.P. An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae. Proc. Natl. Acad. Sci. USA. 93:(5):1996;2192-2197.
76. Legare D., Richard D., Mukhopadhyay R., et al. The Leishmania ABC protein PGPA is an intracellular metal-thiol transporter ATPase. J. Biol. Chem. 276:(28):2001;26301-26307.
77. Fairlamb A.H., Cerami A. Metabolism and functions of trypanothione in the Kinetoplastida. Annu. Rev. Microbiol. 46:1992;695-729.
78. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 52:1983;711-760.
79. Legare D., Papadopoulou B., Roy G., et al. M. Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania. Exp. Parasitol. 87:(3):1997;275-282.
80. Ghosh M., Shen J., Rosen B.P. Pathways of As(III) detoxification in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 96:(9):1999;5001-5006.
81. Ortiz D.F., Ruscitti T., McCue K.F., Ow D.W. Transport of metal-binding peptides by HMT1, a fission yeast ABC-type vacuolar membrane protein. J. Biol. Chem. 270:(9):1995;4721-4728.
82. Fairlamb A.H., Carter N.S., Cunningham M., Smith K. Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Mol. Biochem. Parasitol. 53:(1-2):1992;213-222.
83. Shahi SK. PhD thesis. Molecular characterisation of drug resistance phenotype in Trypanosoma brucei, Heidelberg, University of Heidelberg, 2001.
84. Wirth D, Muhammad Z, Matthew D, Sarah V. ATP-binding cassette (ABC) proteins: from genetic disease to multidrug resistance, Gosau, Austria, 2001. p. 20.
85. Chow L.M.C., Volkman S.K. Plasmodium and Leishmania: the role of mdr genes in mediating drug resistance. Exp. Parasitol. 90:(1):1998;135-141.
86. Foote S.J., Cowman A.F. The mode of action and the mechanism of resistance to antimalarial drugs. Acta Trop. 56:(2-3):1994;157-171.
87. Yayon A., Cabantchik Z.I., Ginsburg H. Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc. Natl. Acad. Sci. USA. 82:(9):1985;2784-2788.
88. Ginsburg H., Geary T.G. Current concepts and new ideas on the mechanism of action of quinoline-containing antimalarials. Biochem. Pharmacol. 36:(10):1987;1567-1576.
89. Ginsburg H., Stein W.D. Kinetic modelling of chloroquine uptake by malaria-infected erythrocytes. Assessment of the factors that may determine drug resistance. Biochem. Pharmacol. 41:(10):1991;1463-1470.
90. Dorn A., Stoffel R., Matile H., Bubendorf A., Ridley R.G. Malarial haemozoin beta-hematin supports heme polymerization in the absence of protein. Nature. 374:(6519):1995;269-271.
91. Sullivan D.J., Gluzman I.Y., Russell D.G., Goldberg D.E. On the molecular mechanism of chloroquine's antimalarial action. Proc. Natl. Acad. Sci. USA. 93:(21):1996;11865-11870.
92. Bray P.G., Mungthin M., Ridley R.G., Ward S.A. Access to hematin: the basis of chloroquine resistance. Mol. Pharmacol. 54:(1):1998;170-179.
93. Slater A.F., Cerami A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature. 355:(6356):1992; 167-169.
94. Sullivan D.J. Jr, Gluzman I.Y., Goldberg D.E. Plasmodium hemozoin formation mediated by histidine-rich proteins. Science. 271:(5246):1996;219-222.
95. Warhurst D. Drug resistance in Plasmodium falciparum malaria. Infect. 27:(Suppl. 2):1999;S55-S58.
96. White N.J. Drug resistance in malaria. Br. Med. Bull. 54:(3):1998;703-715.
97. Price R.N., Cassar C., Brockman A., et al. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 43:(12):1999;2943-2949.
98. Wellems T.E. Plasmodium chloroquine resistance and the search for a replacement antimalarial drug. Science. 298:(559):2002;124-126.
99. Cowman A.F., Foote S.J. Chemotherapy and drug resistance in malaria. Int. J. Parasitol. 20:(4):1990;503-513.
100. Bray P.G., Howells R.E., Ward S.A. Vacuolar acidification and chloroquine sensitivity in Plasmodium falciparum. Biochem. Pharmacol. 43:(6):1992;1219-1227.
101. Foote S.J., Kyle D.E., Martin R.K., et al. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature. 345:(6272):1990;255-258.
102. Cowman A.F., Karcz S., Galatis D., Culvenor J.G. A P-glycoprotein homologue of Plasmodium falciparum is localised on the digestive vacuole. J. Cell Biol. 3:(5):1991;1033-1042.
103. Peel S.A., Merritt S.C., Handy J., Baric R.S. Derivation of highly mefloquine-resistant lines from Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 48:1993;385-397.
104. Wilson C.M., Volkman S.K., Thaithong S., et al. Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol. Biochem. Parasitol. 57:(1):1993;151-160.
105. Barnes D.A., Foote S.J., Galatis D., Kemp D.J., Cowman A.F. Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. EMBO J. 11:(8):1992;3067-3075.
106. Cowman AF, Galatis D, Thompson JK. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine, Proc Natl Acad Sci USA 1994;91(3):1143-47.
107. Peel S.A., Bright P., Yount B., Handy J., Baric R.S. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 51:1994;648-658.
108. Reed M.B., Saliba K.J., Caruana S.R., Kirk K., Cowman A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 403:(6772):2000;906-909.
109. Duraisingh M.T., Roper C., Walliker D., Warhurst D.C. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol. Microbiol. 36:(4):2000;955-961.
110. Volkman S.K., Cowman A.F., Wirth D.F. Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA. 92:(19):1995;8921-8925.
111. Bray P.G., Howley S.R., Mungthin M., Ward S.A. Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. Mol. Pharmacol. 50:(6):1996;1559-1566.
112. Foley M., Tilley L. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol. Therp. 79:(1):1998;55-87.
113. Martin S.K., Odula A.M., Milhous W.K. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science. 235:(4791):1987;899-901.
114. Basco L.K., Le Bras J., Rhoades Z., Wilson C.M. Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. Mol. Biochem. Parasitol. 74:(2):1995;157-166.
115. Wellems T.E., Panton L.J., Gluzman I.Y., et al. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature. 345:(6272):1990;253-255.
116. Wellems T.E., Waker-Jonah A., Panton L.J. Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proc. Natl. Acad. Sci. USA. 88:1991;3382-3386.
117. Su X.Z., Kirkman L.A., Fujioka H., Wellems T.E. Complex polymorphisms in an [similar] 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell. 91:(5):1997;593-603.
118. Fidock D.A., Nomura T., Cooper R.A., Su X., Talley A.K., Wellems T.E. Allelic modifications of the cg2 and cg1 genes do not alter the chloroquine response of drug-resistant Plasmodium falciparum. Mol. Biochem. Parasitol. 110:2000;1-10.
119. Warhurst D.A. Molecular marker for chloroquine-resistant falciparum malaria. New Engl. J. Med. 344:(4):2001;299-302.
120. Wellems T.E., Plowe C.V. Chloroquine-resistant malaria. J. Infect. Dis. 184:(6):2001;770-776.
121. Cooper R.A., Ferding M.T., Su X.Z., et al. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol. Pharmacol. 61:(1):2002;35-42.
122. Howard E.M., Zhang H., Roepe P.D. A novel transporter, pfcrt, confers antimalarial drug resistance. J. Membr. Biol. 190:(1):2002;1-8.
123. Sidhu A.B., Verdier-Pinard D., Fidock D.A. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science. 298:(5591):2002;210-213.
124. Ward S.A., Bray P.G., Mungthin M., Hawley S.R. Current views on the mechanisms of resistance to quinoline-containing drugs in Plasmodium falciparum. Ann. Trop. Med. Parasitol. 89:(2):1995;121-124.
125. Babiker H.A., Pringle S.J., Abdel-Muhsin A., Mackinnon M., Hunt P., Walliker D. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. J. Infect. Dis. 183:(10):2001;1535-1538.
126. Chen N., Russell B., Fowler E., Peters J., Cheng Q. Levels of chloroquine resistance in Plasmodium falciparum are determined by loci other than pfcrt and pfmdr1. J. Infect. Dis. 185:2002;405-407.
127. Bozdech Z., VanWye J., Haldar K., Schurr E. The human malaria parasite Plasmodium falciparum exports the ATP-binding cassette protein PFGCN20 to membrane structures in the host red blood cell. Mol. Biochem. Parasitol. 97:(1-2):1998;81-95.
128. Gardner M.J., Hall N., Fung E., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 419:(6906):2002;498-511.
129. Carlton J.M., Angiuoli S.V., Suh B.B., et al. Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature. 419:(6906):2002;512-519.
130. Chow L.M., Wong A.K., Ullman B., Wirth D.F. Cloning and functional analysis of an extrachromosomally amplified multidrug resistance-like gene in Leishmania enriettii. Mol. Biochem. Parasitol. 60:(2):1993;195-208.
131. Zhang W.W., Sammuelson J. Molecular cloning of the gene for a novel ABC superfamily transporter of Entamoeba histolytica. Mol. Biochem. Parasitol. 62:(1):1993;131-134.
132. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215:(3):1990;403-410.
133. Pearson W.R. Rapid and sensitive sequence comparison with FASTP and FASTA. Methods Enzymol. 183:1990;63-98.
134. Altschul S.F., Madden T.L., Schaffer A.A., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:(17):1997;3389-3402.
135. Saurin W., Hofnung M., Dassa E. Getting in or out: early segregation between importers and exporters in the evolution of ATP-binding cassette (ABC) transporters. J. Mol. Evol. 48:1999;22-41.
136. Schaffer A.A., Aravind L., et al. Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. Nucleic Acids Res. 29:(14):2001;2994-3005.
137. Higgins D., Thompson J., Gibson T., Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680.
138. VandePeer Y., DeWachter R. TREECON - a software package for the construction and drawing of evolutionary trees. Comput. Appl. Biosci. 9:(2):1994;177-182.
139. Saitou N., Nei M. The neighbor-joining method - a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:(4):1987;406-425.
140. Francis S.E., Sullivan D.J. Jr, Goldberg D.E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51:1997;97-123.
141. Ginsburg H., Krugliak M. Chloroquine-some open questions on its antimalarial mode of action and resistance. Drug Resist. Update. 2:(3):1999;180-187.
142. Kirk K. Membrane transport in the malaria-infected erythrocyte. Physiol. Rev. 81:(2):2001;495-537.